Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Porter

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Seminars in Oncology|September 1, 1986
High-dose pilot studies in extensive-stage small-cell lung cancerD H Johnson, K R Hande, L L Porter, et al.
The American Journal of Medicine|December 1, 1986
Acute nonlymphocytic leukemia after treatment of small cell lung cancerD H Johnson, L L Porter, A F List, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposideD H Johnson, S N Wolff, J D Hainsworth, et al.
Cancer Treatment Reports|March 1, 1986
Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study GroupJ D Hainsworth, L L Porter, D H Johnson, et al.
Clinical Lung Cancer|January 17, 2004
A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) TrialH Choy, R F DeVore, K R Hande, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2001
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trialH Choy, R F DeVore, K R Hande, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)H Choy, R F Devore, K R Hande, et al.
Seminars in Oncology|August 1, 1997
Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancerH Choy, R F DeVore, K R Hande, et al.
The Cancer Journal From Scientific American|January 1, 1997
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study GroupT H Grote, L F Pineda, R A Figlin, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Seminars in Oncology|March 1, 1985
High-dose etoposide (VP-16) in small-cell lung cancerF A Greco, D H Johnson, K R Hande, et al.
Seminars in Oncology|September 1, 1986
High-dose pilot studies in extensive-stage small-cell lung cancerD H Johnson, K R Hande, L L Porter, et al.
The American Journal of Medicine|December 1, 1986
Acute nonlymphocytic leukemia after treatment of small cell lung cancerD H Johnson, L L Porter, A F List, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposideD H Johnson, S N Wolff, J D Hainsworth, et al.
Cancer Treatment Reports|March 1, 1986
Combination chemotherapy with vindesine, etoposide, and cisplatin in non-small cell lung cancer: a pilot study of the Southeastern Cancer Study GroupJ D Hainsworth, L L Porter, D H Johnson, et al.
Clinical Lung Cancer|January 17, 2004
A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) TrialH Choy, R F DeVore, K R Hande, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2001
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trialH Choy, R F DeVore, K R Hande, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)H Choy, R F Devore, K R Hande, et al.
Seminars in Oncology|August 1, 1997
Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancerH Choy, R F DeVore, K R Hande, et al.
The Cancer Journal From Scientific American|January 1, 1997
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study GroupT H Grote, L F Pineda, R A Figlin, et al.
Pageof 3